Cell Therapy Technologies Market

Market Leader - Cell Therapy Technologies Market

The cell therapy technologies market is projected to reach USD 5.6 billion by 2025 from USD 2.8 billion in 2020, at a CAGR of 14.4% from 2020 to 2025. Cell therapy refers to the introduction of new and healthy cells into the patient’s body to replace diseased or missing ones. New technologies and innovative products have enabled many different types of cells to treat diseases and conditions. Some of these cells are hematopoietic (blood-forming) stem cells (HSC), skeletal muscle stem cells, mesenchymal stem cells, lymphocytes, dendritic cells, and pancreatic islet cells. The growth of this market is driven by the rising government investments in cell-based research, increasing incidence of chronic and infectious diseases, large number of oncology-related cell therapy clinical trials, and increasing GMP certifications for cell therapy production facilities.

The cell therapy technologies market is a highly fragmented market and is dominated by various players. The major players operating in this market are Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), and Becton, Dickinson and Company (US). Other players in the market include, Lonza Group (Switzerland), Terumo BCT (US), Fresenius Medical Care AG & Co. KGaA (Germany), Avantor, Inc. (US), Bio-Techne Corporation (US), Corning Incorporated (US), FUJIFILM Irvine Scientific (US), MaxCyte (US), Werum IT Solutions GmbH (Germany), RoosterBio Inc. (US), SIRION Biotech GmbH (Germany), CellGenix GmbH (Germany), L7 Informatics, Inc. (US), Miltenyi Biotec GmbH (Germany), STEMCELL Technologies (Canada), Hemasoft (US), MAK-SYSTEM (US), OrganaBio, LLC (US), IxCells Biotechnology (China), and Wilson Wolf Corporation (US).

To know about the assumptions considered for the study download the pdf brochure

Thermo Fisher Scientific (US)

Thermo Fisher was the largest player in the cell therapy technologies market in 2019. It has focused on expansion to maintain its position in the market and expand its product portfolio. For instance, in May 2020, Thermo Fisher Scientific expanded its capacity for viral vector development and manufacturing services with a new commercial manufacturing site in Plainville, Massachusetts.

Merck KGaA (Germany)

Merck ranked second in the cell therapy technologies market in 2019. The company has a strong life sciences product portfolio and is engaged in establishing new sites to enhance its manufacturing and distribution capabilities. In February 2018, Merck invested EUR 40 million to enhance its capabilities in the Asian market. These developments have helped the company to offer better products in the market.

Related Reports:

Cell Therapy Technologies Market by Product [Consumables, Equipment (Single-Use Equipment, Other Equipment), Systems & Software], Process (Cell Processing), Cell Type (T-cells, Stem Cells), End User (Research Institutes) - Global Forecast to 2025

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Report Code
BT 6823
RI Published ON
10/28/2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Cell Therapy Technologies Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved